Oil prices are having a down year. Brent, the global benchmark price, has fallen 15% to around $63 a barrel. That slump has ...

Pharmaceutical giant Bristol Myers Squibb is currently offering a 4.7% yield. The dividend hasn't been increased every single ...

CEO Mike Wirth said on Tuesday he is in discussions with the board of directors about when he will step down from ...

As of December 11, 2025, the index has risen 10.32% during the previous 12 months and 14.89% so far in 2025. It climbed by 13.62% during the last six months, maintaining its gain of 1.62% last month.

XOM lifts Permian growth with new proppant tech and fresh Midland acreage as it works toward 2.3M barrels a day by 2030.

Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the State Street SPDR S&P Dividend ETF (SDY), a passively managed exchange traded ...

Suncor's strong execution, lower breakevens, and 100% excess cash returns position it ahead of Chevron heading into 2026.

In early December 2025, Chevron’s board approved amended and restated by-laws that modernize officer roles, clarify director election mechanics, and designate Delaware courts as the exclusive forum ...

RNA interference drug developer SanegeneBio leads our round-up of this week's biotech financings, with a $110 million Series ...

On Dec. 9, 2025, Exxon Mobil Corporation XOM announced its 2030 corporate forecast, following which its share price rose 3.07 ...

According to TipRanks.com, Gabelman is a 4-star analyst with an average return of 7.3% and a 57.6% success rate. Gabelman covers the NA sector, focusing on stocks such as Enterprise Products Partners, ...